IPG Photonics entered into a Put Option Agreement with Lumibird to acquire 100% of Lumibird Medical for €300 million on a cash-free, debt-free basis, plus up to €50 million in contingent earnout tied to 2026–2027 performance. The deal will be funded with cash on hand and includes an exclusivity undertaking from Lumibird. Completion remains subject to the French works council consultation and regulatory approvals, including French foreign investment clearance, with closing targeted for Q4 2026. A form of Share Purchase Agreement is appended to the option and a warranty and indemnity insurance policy will backstop certain representations.
Agreement details:
- Agreement type: Put Option Agreement for 100% acquisition of Lumibird Medical
- Counterparty: Lumibird
- Signed / Effective: Jul 16 2026 / Jul 16 2026
- Duration / Termination: Up to 6 months (earlier upon SPA execution or 10 days post consultation)
- Reason: Expand medical laser business and diversify revenue
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.